Showing results (121-130 of 200) with videos related to
Sort By:
Pageof 20
Journal of Nephrology|July 22, 2025
Body water distribution, early malnutrition and sarcopenia in ADPKD: insights from a cross sectional studyMaria Teresa Sciarrone Alibrandi, Matteo Brambilla Pisoni, Rodolfo Fernando Rivera, et al.Advanced Materials (Deerfield Beach, Fla.)|July 3, 2023
Mechanoluminescence and Photoluminescence Heterojunction for Superior Multimode Sensing Platform of Friction, Force, Pressure, and Temperature in Fibers and 3D-Printed PolymersTeng Zheng, Marcin Runowski, Inocencio R Martín, et al.Acta Oncologica (Stockholm, Sweden)|October 25, 2007
Colorectal cancer metastasis resectability after treatment with the combination of oxaliplatin, irinotecan and 5-fluorouracil. Final results of a phase II studyAlbert Abad, Bartomeu Massuti, Antonio Antón, et al.BMC Cancer|September 24, 2013
Antiproliferative effects of lanreotide autogel in patients with progressive, well-differentiated neuroendocrine tumours: a Spanish, multicentre, open-label, single arm phase II studyMarta Martín-Richard, Bartomeu Massutí, Eva Pineda, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 8, 2025
Predictive factors of efficacy for FTD/TPI plus bevacizumab in refractory metastatic colorectal cancer patients: a subanalysis of the Spanish cohort from the SUNLIGHT phase III trialGemma Soler, Cristina Grávalos, Fernando Rivera, et al.Journal of Primary Care & Community Health|August 29, 2022
Depression: A Modifiable Risk Factor for Poor Outcomes in FibromyalgiaBala Munipalli, Madeleine E Allman, Mohit Chauhan, et al.Current Oncology (Toronto, Ont.)|June 27, 2023
Impact of the COVID-19 Lockdown on Physical Activity Levels and Health Parameters in Young Adults with CancerMónica Castellanos-Montealegre, Fernando Rivera-Theruel, Virginia García-Coll, et al.Cancer Chemotherapy and Pharmacology|October 7, 2019
Correction to: Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trialFernando Rivera, C Romero, P Jimenez-Fonseca, et al.Cancer Chemotherapy and Pharmacology|March 31, 2019
Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trialFernando Rivera, C Romero, P Jimenez-Fonseca, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 3, 2007
Long term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in non-resectable locally advanced (stage IV-B) squamous cell head and neck carcinoma and peripheral blood stem cell support (PBSCS) with febrile neutropeniaFernando Rivera, María E Vega-Villegas, Marta F López-Brea, et al.Pageof 20